Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Targeted Next-Generation Sequencing of Cell-Free DNA in Diffuse Large B-Cell Lymphoma

Wei Zhang, MD, Min Xiao, MD PhD, Jianfeng Zhou, PhD, Ken H. Young, MD PhD

Blood (2018) 132 (Supplement 1): 4212.

https://doi.org/10.1182/blood-2018-99-116847

Published: 2018

Journal Articles

Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

Blood (2018) 132 (Supplement 1): 148.

https://doi.org/10.1182/blood-2018-99-117956

Published: 2018

Journal Articles

Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30 + Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

Di Wang, MD PhD, Yi Xiao, MD PhD, Chunrui Li, MDPhD, Na Wang, MD PhD, Liang Huang, MDPhD, Yicheng Zhang, MDPhD, Tongcun Zhang, PhD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 1660.

https://doi.org/10.1182/blood-2018-99-116741

Published: 2018

Journal Articles

SHP-1 As a Negative Regulator of FLT3 Associated Aberrant Signaling and a New Potential Target to FLT3-ITD Mutation

Tongjuan Li, MD PhD, Dan Li, Lei Zhao, MD, Jue Wang, MD PhD, Zhen Shang, MD PhD, Yicheng Zhang, MD PhD, Liang Huang, MD PhD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 4051.

https://doi.org/10.1182/blood-2018-99-115793

Published: 2018

Journal Articles

OPN Maintains Leukemia Stem Cells Survival By Suppressing PUMA

Xing Chen, MD, Weiping Yuan, PhD MD, Yi Luo, MD PhD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 4052.

https://doi.org/10.1182/blood-2018-99-116162

Published: 2018

Journal Articles

Droplet Digital PCR Monitoring of TP53 Mutated Circulating Tumor DNA Levels in Lymphoma Patients

Xiaolu Long, Jia Gu, Yaoyao Lou, Qian Xu, Haodong Cai, MD, Wei Zhang, MD, Kefeng Shen, Min Xiao, MD PhD, Yicheng Zhang, MD PhD, Liting Chen, PhD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 4106.

https://doi.org/10.1182/blood-2018-99-113825

Published: 2018

Journal Articles

Effect of Metabolic Reprogramming on the Biological Activity of Acute Myeloid Leukemia Cells

Tongyuan Liu, MD, Dengju Li, MD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 5227.

https://doi.org/10.1182/blood-2018-99-115654

Published: 2018

Journal Articles

Synergy between FLT3-ITD and p53 Haploinsufficiency or Loss in the Development of Acute Myeloid Leukemia

Zengkai Pan, MD PhD, Min Yang, Kezhi Huang, MD PhD, Guntram Buesche, MD, Gudrun Göhring, MD, Michaela Scherr, PhD, Matthias Gaestel, PhD, Matthias Eder, MD, Julia Skokowa, MDPhD, Jianfeng Zhou, PhD, Karl Welte, Li-Gen Liu, MD, Arnold Ganser, MD, Zhixiong Li, MD

Blood (2018) 132 (Supplement 1): 771.

https://doi.org/10.1182/blood-2018-99-110770

Published: 2018

Journal Articles

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

Yuqin Song, MD PhD, Quanli Gao, MD, Huilai Zhang, PhD, Lei Fan, MD PhD, Jianfeng Zhou, PhD, Dehui Zou, MD, Wei Li, MD, Haiyan Yang, PhD, Ting Liu, MD, Quanshun Wang, MD PhD, Fangfang Lv, MD, Yu Yang, MD, Haiyi Guo, MD, Liudi Yang, MD, Rebecca Elstrom, MD, Jane Huang, MD, William Novotny, MD, Vivian Wei, PhD, Jun Zhu, MD PhD

Blood (2018) 132 (Supplement 1): 682.

https://doi.org/10.1182/blood-2018-99-117848

Published: 2018

Journal Articles

Identification of APP As a Novel Candidate Familial Eosinophilia Predisposition Gene

Dan Liu, Peiling Zhang, MD, Fuhong He, PhD, Yueying Li, MD, Wenbing Liu, Xin Liu, PhD, Qianfei Wang, PhD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 3681.

https://doi.org/10.1182/blood-2018-99-117495

Published: 2018

Journal Articles

CAR22/19 Cocktail Therapy for Patients with Refractory/Relapsed B-Cell Malignancies

Liang Huang, MDPhD, Na Wang, MD PhD, Yang Cao, Chunrui Li, MDPhD, Yi Xiao, MD PhD, Min Xiao, MD PhD, Xiaoxi Zhou, MD, PhD, Gaoxiang Wang, MDPhD, Zhenya Hong, MD, PhD, Miao Zhen, MD, PhD, Weixu Meng, MD PhD, Bin Zhang, PhD, Yicheng Zhang, MDPhD, Guido Marcucci, Tongcun Zhang, PhD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 1408.

https://doi.org/10.1182/blood-2018-99-113714

Published: 2018

Journal Articles

The Comparison of the Cytobiological Role of Bone Marrow CD4 + T Cells in Aplastic Anemia Patients and Healthy Subjects.

Miao Zheng, MD, Wenli Liu, Jianfeng Zhou, PhD, Hanying Sun, Yicheng Zhang, PhD

Blood (2007) 110 (11): 3758.

https://doi.org/10.1182/blood.V110.11.3758.3758

Published: 2007

Journal Articles

Screening of Pathogenicity-Related Genes in Bone Marrow CD4 + T Cells of Aplastic Anemia Patients.

Miao Zheng, MD, Wenli Liu, Hanying Sun, Jianfeng Zhou, PhD, Yicheng Zhang, PhD

Blood (2007) 110 (11): 3760.

https://doi.org/10.1182/blood.V110.11.3760.3760

Published: 2007

Journal Articles

The Effects of Tcf-1 Gene Silence on Marrow CD4 + T Cells from Aplastic Anemia Patients.

Miao Zheng, MD, Wenli Liu, Hanying Sun, Jianfeng Zhou, PhD, Yicheng Zhang, PhD

Blood (2007) 110 (11): 3761.

https://doi.org/10.1182/blood.V110.11.3761.3761

Published: 2007

Journal Articles

A Novel Target of Histone Deacetylase Inhibitor, Involves in Mitochondria Membrane Protein Ubiquitination and Regulates Apoptosis.

Peng Wu, PHD, Yang Cao, PHD, Yuan Tian, PHD, Zhenya Hong, PHD, Lishi Sun, PHD, Lingli Gui, PHD, Yicheng Zhang, PHD, Ding Ma, PHD, Jianfeng Zhou, PhD

Blood (2007) 110 (11): 4187.

https://doi.org/10.1182/blood.V110.11.4187.4187

Published: 2007

Journal Articles

A Study on t(9;22)(q34;q11) in Endothelial Cells in Chronic Myeloid Leukemia.

Liang Huang, PHD, Jingyi Wu, PHD, Miao Zheng, PHD, Mei Huang, PHD, Yicheng Zhang, PHD, Jianfeng Zhou, PhD

Blood (2007) 110 (11): 4125.

https://doi.org/10.1182/blood.V110.11.4125.4125

Published: 2007

NARROW

Targeted Next-Generation Sequencing of Cell-Free DNA in Diffuse Large B-Cell Lymphoma

Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial

Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30 + Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

SHP-1 As a Negative Regulator of FLT3 Associated Aberrant Signaling and a New Potential Target to FLT3-ITD Mutation

OPN Maintains Leukemia Stem Cells Survival By Suppressing PUMA

Droplet Digital PCR Monitoring of TP53 Mutated Circulating Tumor DNA Levels in Lymphoma Patients

Effect of Metabolic Reprogramming on the Biological Activity of Acute Myeloid Leukemia Cells

Synergy between FLT3-ITD and p53 Haploinsufficiency or Loss in the Development of Acute Myeloid Leukemia

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

Identification of APP As a Novel Candidate Familial Eosinophilia Predisposition Gene

CAR22/19 Cocktail Therapy for Patients with Refractory/Relapsed B-Cell Malignancies

The Comparison of the Cytobiological Role of Bone Marrow CD4 + T Cells in Aplastic Anemia Patients and Healthy Subjects.

Screening of Pathogenicity-Related Genes in Bone Marrow CD4 + T Cells of Aplastic Anemia Patients.

The Effects of Tcf-1 Gene Silence on Marrow CD4 + T Cells from Aplastic Anemia Patients.

A Novel Target of Histone Deacetylase Inhibitor, Involves in Mitochondria Membrane Protein Ubiquitination and Regulates Apoptosis.

A Study on t(9;22)(q34;q11) in Endothelial Cells in Chronic Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only